ITMCTR2200006710尚未招募1 期
A randomized, double-blind, cross-over clinical trial of Sinisan in improving depression state of breast cancer patients with mild to moderate depression
Zhiyu Wang0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 75（—）
- 性别
- Female
入选标准
- •(1) Pathologically diagnosed breast cancer patient, in line with clinical diagnosis of breast cancer;
- •(2) 18 years to 75 years old;
- •(3) Combined with PHQ -9 and Hamd -24, the patients were diagnosed as mild to moderate depression by psychologists;
- •(4) Theoretically Diagnosed stagnation of liver-qi syndrome of Traditional Chinese medicine;
- •(5) ECOG=2;
- •(6) Be able to understand the questions in the scale and complete it;
- •(7) Volunteer to participate in the clinical study and sign the informed consent.
排除标准
- •(1) Pregnant or lactating women;
- •(2) Patients with history of other malignant tumors;
- •(3) Patients with diagnosed major depressive disorder;
- •(4) Patients with cardiovascular diseases , liver and kidney dysfunction and other serious diseases;
- •(5) Previous diagnosis of mental disorder or Bipolar Disorder; alcohol and drug abusing history;
- •(6) patients who used antidepressant, antipsychotics or accept any form of psychological treatment within 2 weeks before treatment;
- •(7) patients who were participating in other clinical trials.
研究者
相似试验
进行中（未招募）
不适用
A double-blinded, randomized, crossover clinical study to assess the efficacy of Qutenza (capsaicin 8% patches) for the reduction of site pain caused by continuous subcutaneous infusion of Remodulin (treprostinil sodium), in Pulmonary Arterial Hypertension Patients - Efficacy of capsaicin 8% patches in Pulmonary Arterial HypertensioPulmonary arterial hypertension (PAH) is a rare life-threatening disease characterised by high blood pressure in the arteries to the lungs, rapidly evolving in a clinical syndrome of dyspnoea and fatigue and eventually leading to right ventricular failure and death.MedDRA version: 13.1Level: PTClassification code 10037400Term: Pulmonary hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-001312-59-GBImperial College London
进行中（未招募）
1 期
Clinical trial to assess the efficacy and safety of Montelukast in patients with erosive / inflammatory arthrosis of the handsErosive / inflammatory arthrosis of the handsMedDRA version: 20.0Level: LLTClassification code 10003416Term: ArthrosisSystem Organ Class: 100000004859EUCTR2021-001465-20-ESaboratorios Farmalíder S.A.280
进行中（未招募）
不适用
A clinical trial to assess the Efficacy and safety of liposomal Curcumin in subjects with metabolic syndromeCTRI/2017/06/008903CureSupport
已完成
不适用
A randomized, double blind, controlled clinical trial of S-Amlodipine versus conventional Amlodipine, to compare the incidence of leg edema and antihypertensive efficacy in patients with hypertensioHypertension, leg oedemaSLCTR/2013/006Emcure Pharmaceuticals Limited
尚未招募
2 期
A randomized, double-blind, controlled clinical trial of Suhe Granules for chronic insomnia patients with Disharmony of Qi and Blood and Deficiency of Heart and KidneyinsomniaITMCTR2200006603Guangdong Provincial Hospitai of Chinese Medicine